What is Eucrisa (crisaborole) and what does it treat?
Eucrisa (crisaborole) is a prescription topical medication used to treat mild to moderate atopic dermatitis (eczema) in patients aged 3 months and older.
How do you use Eucrisa (application instructions)?
Eucrisa is applied as a thin layer to the affected skin areas. Typical instructions are to apply it twice daily and continue use as directed by a clinician.
Who can use Eucrisa?
Eucrisa is approved for patients aged 3 months and older. It is intended for use on affected skin areas rather than the entire body unless a clinician directs otherwise.
What are the common side effects patients ask about?
The most commonly reported adverse effects are application-site reactions, especially burning, stinging, or irritation where the cream is applied.
When should you avoid Eucrisa or get medical advice?
Patients should not apply Eucrisa to areas of the skin that are severely irritated or appear infected unless a clinician tells them to. If significant worsening occurs, the treatment should be reassessed with a healthcare professional.
Is Eucrisa available as a generic?
Search results for exclusivity and patent status depend on the specific strength/formulation and the latest filings. For up-to-date information on patent and market exclusivity, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
Patient questions: Can Eucrisa be used with other eczema treatments?
Eucrisa is generally used as part of an atopic dermatitis regimen, but the exact combination with other topical products (such as moisturizers, topical steroids, or other emollients) should follow the prescriber’s plan to avoid irritation at the application site.
Safety timing: What to do if burning or irritation is severe?
Mild burning or irritation can occur with topical crisaborole. If symptoms are strong, persist, or the skin looks worse than before treatment, patients should stop using it and contact the prescriber.
Sources
- [1] https://www.drugpatentwatch.com/